China Pharma Inc. (CPHI)
AMEX: CPHI
· Real-Time Price · USD
1.46
0.00 (0.00%)
At close: Aug 15, 2025, 9:59 AM
China Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1,136.3B | 1.13M | 1.1M | 924.94K | 1.37M | 2.15M | 1.8M | 1.1M | 1.96M | 2.92M | 1.97M | 1.61M | 1.6M | 2.89M | 1.98M | 2.42M | 2.36M |
Cost of Revenue | 1,272.3B | 1.29M | 1.62M | 2.05M | 1.66M | 2.29M | 2.04M | 1.24M | 1.78M | 2.88M | 2.1M | 1.84M | 1.77M | 2.59M | 2.28M | 2.34M | 2.09M |
Gross Profit | -136.06B | -160.59K | -519.65K | -1.12M | -290.02K | -141.42K | -233.19K | -146.66K | 177.92K | 42.68K | -137.76K | -229.38K | -169.46K | 301.94K | -296.4K | 71K | 272.73K |
Operating Income | -758.62B | -1.2M | -1.09M | -1.39M | -916.05K | -1.18M | -713.54K | -456.31K | 953.2K | -1.18M | -688.65K | -779.59K | -911.72K | 772.74K | -762.4K | -752.95K | -696.47K |
Interest Income | 1.07B | 1.33K | 1.46K | 1.53K | 2.31K | 2.53K | 2.18K | 942.00 | 948.00 | 1K | 1.86K | 1.24K | 6.66K | 1.41K | 638.00 | 579.00 | 406.00 |
Pretax Income | -785.57B | -1.22M | -1.12M | -1.44M | -955.89K | -1.23M | -777.6K | -593.03K | -475.98K | -1.26M | -790.77K | -888.39K | -1.03M | -980.72K | -826.67K | -824.76K | -767.33K |
Net Income | -785.57B | -1.22M | -1.12M | -1.44M | -955.89K | -1.23M | -777.6K | -593.03K | -1.99M | -1.35M | -790.77K | -2.47M | -2.69M | -3.07M | -826.67K | -824.76K | -767.33K |
Selling & General & Admin | 594.29B | 1.03M | 479.65K | 203.32K | 596.64K | 895.52K | 452.79K | 281.85K | 562.43K | 1.18M | 535.99K | 535.15K | 688.21K | 1.15M | 436.26K | 770.49K | 787.33K |
Research & Development | 29.59B | 547.00 | 87.61K | 164.33K | 31.45K | 147.55K | 45.77K | 23.75K | 23.01K | 28K | 88.75K | 15.06K | 54.05K | 54.05K | 21.37K | 53.46K | 190.09K |
Other Expenses | n/a | 948.00 | n/a | -96.45K | -2.07K | n/a | n/a | n/a | 10.04K | 10.14K | n/a | 4.36K | 5.52K | n/a | 8.37B | n/a | n/a |
Operating Expenses | 623.88B | 895.12K | 565.61K | 271.21K | 626.03K | 1.04M | 498.56K | 305.6K | 585.44K | 1.22M | 624.73K | 554.57K | 747.78K | -950.63K | -466.01K | -823.95K | -969.2K |
Interest Expense | -28.03B | 29.73K | 34.11K | 48.14K | 42.16K | 50.25K | 66.24K | 137.66K | 79.44K | 96.17K | 103.98K | 110.04K | 124.43K | 333.44K | 64.9K | 72.39K | 71.27K |
Selling & Marketing Expenses | 87.11B | 174.58K | 134.6K | 111.45K | 108.19K | 259.55K | 206.52K | 169.82K | 144.43K | 364.4K | 259.38K | 266.45K | 179.56K | 536.9K | 134.29K | 445.48K | 378.33K |
Cost & Expenses | 1,896.2B | 2.33M | 2.19M | 2.32M | 2.29M | 3.33M | 2.54M | 1.55M | 1.21M | 1.67M | 2.73M | 1.29M | 1.03M | 1.64M | 1.81M | 1.52M | 1.12M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 3.00 | n/a | n/a | 1.52M | 83.72K | n/a | 1.58M | 1.66M | 2.09M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 32.62M | 17.46M | 17.31M | 16.12M | 13.13M | 10.63M | 10.57M | 9.92M | 8.08M | 6.44M | 4.61M | 4.85M | 4.74M | 4.78M | 4.61M | 4.61M | 4.61M |
Shares Outstanding (Diluted) | 32.62M | 17.46M | 17.31M | 16.12M | 13.13M | 10.63M | 10.57M | 9.92M | 8.08M | 6.44M | 4.61M | 4.94M | 4.74M | 4.78M | 4.61M | 4.61M | 4.61M |
EPS (Basic) | -24.08K | -0.07 | -0.06 | -0.09 | -0.07 | -0.12 | -0.07 | -0.06 | -0.25 | -0.21 | -0.79 | -0.51 | -0.57 | -0.64 | -0.18 | -0.18 | -0.17 |
EPS (Diluted) | -24.08K | -0.07 | -0.06 | -0.09 | -0.07 | -0.12 | -0.07 | -0.06 | -0.25 | -0.21 | -0.79 | -0.5 | -0.57 | -0.64 | -0.18 | -0.18 | -0.17 |
EBITDA | -758.62B | -746.63K | -386.85K | -648.35K | -179.94K | -486.12K | -28.27K | 240.77K | 283.35K | -528.58K | -22.46K | -94.74K | -191.51K | 63.44K | 214.69K | -51.91K | 4.13K |
EBIT | n/a | -1.19M | -1.08M | -1.39M | -913.74K | -1.18M | -711.36K | -455.37K | -396.53K | -1.17M | -686.8K | -778.35K | -905.06K | -647.28K | -761.77K | -752.37K | -696.06K |
Depreciation & Amortization | n/a | 448.07K | 696.94K | 741.64K | 733.8K | 695.84K | 683.09K | 696.14K | 679.88K | 639.42K | 664.34K | 683.61K | 713.56K | 710.72K | 976.46K | 700.46K | 700.19K |